Vaccine against ovarian cancer developed
Researchers from Oxford University They are developing what could be the world’s first vaccine against ovarian cancer. An unprecedented step that will radically change the process of preventing this disease and which could be ready in the next three years.
For this, what do these experts want to achieve with the future vaccine? Waxing ovaries is to train the immune system to recognize and fight ovarian cancer. its earliest stages, before it becomes a bigger problem. A study that is already being intensively worked on at the University of Oxford with the intention that women can receive the vaccine prophylactically and thus reduce their existing chances of contracting this type of cancer.
Regarding the analysis process, researchers are working to discover proteins found on the surface of cancer cells. Once this is done, the team will conduct human clinical trials, first on people carrying the BRCA1 and BRCA2 genetic mutations, where the likelihood of developing ovarian and breast cancer increases significantly, reaching 65%.
“We need better strategies to prevent ovarian cancer. Currently, women with BRCA1-2 mutations who are at very high risk receive surgery that prevents cancer but makes it impossible to have children later,” says Ahmed Ahmed, project manager. Moreover, he also adds that “there are many types of ovarian cancer that are not detected until they are at a much later stage.”
Looking at the statistics of people who have this mutation, they all They note that they may develop cancer before the age of 80. ovarian cancer and most importantly, these people make up 2% of the total population. This vaccine will prevent spay removal, giving them a more effective and less invasive method of fighting this disease.